Skip to main content

Media centre

The Breakthrough T1D Media team is here to help journalists and producers with information on type 1 diabetes research, with facts and figures about type 1 diabetes, position statements, information on the celebrities giving their backing to Breakthrough T1D and with any other enquiries.
Content last reviewed and updated: 15.12.2025

Are you a journalist seeking information about type 1 diabetes and our mission to prevent, treat and cure the condition? We are able to provide members of the media with:

Media enquiries in the UK

For all media enquiries in the UK please email pressoffice@breakthrought1d.org.uk. This email is monitored between 09:00 and 17:30 Monday to Friday.

Please note: the above email address is for enquiries from the media/journalists only. Please email info@breakthrought1d.org.uk with all other enquiries.

Media enquiries in the US

For all enquiries in the US please email media@BreakthroughT1D.org.

Latest news

Read more
CamAPS Liberty
Type 1 technology
9 June 2026

CamAPS Liberty®: behind the headlines

You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know…

Read more
ADA 2026 logo
Breakthrough T1D
8 June 2026

12 of 12 trial participants are no longer injecting insulin, thanks to new immunosuppressive drug tegoprubart

New data presented this week at the American Diabetes Association’s (ADA) 86th Scientific Sessions shows incredible promise: all 12 participants in the Eledon trial, testing the immunosuppressive drug tegoprubart, are no longer injecting insulin.

Read more
Manisha feeding baby Dillan
Breakthrough T1D
3 June 2026

NICE publish new guidance on hybrid closed loop systems for pregnancy 

In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.

Read more
Breakthrough T1D
2 June 2026

Steve Morgan Foundation funding to boost psychological support for young people with T1D

The Steve Morgan Foundation has donated £280,000 to Breakthrough T1D and DigiBete to expand Coping with Diabetes online tool.

Read more
A black and white image of Kate Moss, alongside the Breakthrough T1D logo on Piccadilly Lights
Breakthrough T1D
18 May 2026

Breakthrough T1D appears on Piccadilly Lights alongside EE72 FILM starring Kate Moss

On Friday 15 May, Breakthrough T1D appeared on Piccadilly Lights alongside a new short film for EE72 featuring Kate Moss, captured by Nick Knight.

Read more
Colin Brumpton
Breakthrough T1D
17 April 2026

A tribute to Colin Brumpton

We are very sorry to share the news that Colin Brumpton, Entrepreneur, Business Consultant and a long‑standing supporter of Breakthrough T1D, passed away on 14 April.

Read more
Breakthrough T1D
30 March 2026

Three key themes for ATTD 2026

Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.

Read more
Scientist researcher woman in white coat using microscope in laboratory
Breakthrough T1D
16 March 2026

Positive 14-month follow-up data from Sana Biotechnology gives hope for people with type 1 diabetes

These lab-engineered cells have been able to evade the immune system and produce insulin for 14 months without the need for immunosuppression.